| 國立臺灣大學 |
2001-12 |
Tumor necrosis factor--induced apoptosis in cord blood T lymphocytes: involvement of both tumor necrosis factor receptor types 1 and 2
|
Yang, Ya-Chien; Hsu, Tsuey-Ying; Chen, Jen-Yang; Yang, Czau-Siung; Lin, Rong-Hwa |
| 臺大學術典藏 |
2020-11-02T02:05:30Z |
Tumor necrosis factor-�\ and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma
|
Wang H.-P.; Lin J.-T.; Lin M.-T.; Chang M.-C.; Shun C.-T.; Chang Y.-T.; Huang S.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:47:56Z |
Tumor necrosis factor: The key to hepatitis B viral clearance
|
Chyuan I.-T.; PING-NING HSU |
| 中國醫藥大學 |
2014-08-28 |
Tumor necrosis factors, molds and Asthma in Children: A Haplotype-Based Analysis.
|
黃鈺斯(Yu-Sih Huang);李郁芬(Yu-Fen Li);戴婷豫(Ting-Yu Tai);林育廷(Yu-Ting Lin);黃彬芳(Bing-Fang Hwang);黃彬芳(Bing-Fang Hwang) |
| 國立臺灣大學 |
2001 |
Tumor necrosis factor-induced activation of downstream NF-kB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: Involvement of PKC, tyrosine kinase and IKK2, but not MAPKs
|
Chen, Ching-Chow; Chou, Chian-Ying; Sun, Yi-Tao; Huang, Wei-Chien |
| 國立成功大學 |
2021-07 |
Tumor Necrosis with Adjunction of Preoperative Monocyte-to-Lymphocyte Ratio as a New Risk Stratification Marker Can Independently Predict Poor Outcomes in Upper Tract Urothelial Carcinoma
|
Lin;Kun-Che;Jan;Hau-Chern;Hu;Che-Yuan;Ou;Yin-Chien;Kao;Yao-Lin;Yang;Wen-Horng;Ou;Chien-Hui |
| 國立臺灣大學 |
2007-11 |
Tumor necrotizing factor-a and GST-T1 genotype predict skin allergy to chromate in cement workers in Taiwan
|
Wang, BJ; Shiao, JSC; Chen, CJ; Lee, YC; Guo, YL |
| 臺大學術典藏 |
2019-03-04T08:13:58Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin, Shu Yung;Yang, Ching Yao;Bin-Chi Liao;Chao-Chi Ho;Wei-Yu Liao;Chen, Kuan-Yu;Tsai, Tzu Hsiu;Chia-Lin Hsu;Hsu, Wei Hsun;Kang-Yi Su;Yih-Leong Chang;Lee, Jih Hsiang;Lin, Chia Chi;Jin-Yuan Shih;Yang, James Chih Hsin;Chong-Jen Yu; Lin, Shu Yung; Yang, Ching Yao; BIN-CHI LIAO; CHAO-CHI HO; WEI-YU LIAO; Chen, Kuan-Yu; Tsai, Tzu Hsiu; CHIA-LIN HSU; Hsu, Wei Hsun; KANG-YI SU; YIH-LEONG CHANG; Lee, Jih Hsiang; Lin, Chia Chi; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2020-03-06T05:26:04Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2020-03-07T06:56:12Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Yih-Leong Chang;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; YIH-LEONG CHANG; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
